The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Aquestive Therapeutics Inc (NASDAQ: AQST) was $2.75 for the day, down -3.85% from the previous closing price of $2.86. In other words, the price has decreased by -$3.85 from its previous closing price. On the day, 0.93 million shares were traded. AQST stock price reached its highest trading level at $2.84 during the session, while it also had its lowest trading level at $2.71.
Ratios:
Our analysis of AQST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.36 and its Current Ratio is at 4.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on December 17, 2024, initiated with a Overweight rating and assigned the stock a target price of $17.
On May 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $8.
On April 11, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $10.Piper Sandler initiated its Overweight rating on April 11, 2024, with a $10 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 26 ’24 when Jung Cassie sold 44 shares for $4.87 per share. The transaction valued at 214 led to the insider holds 0 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AQST now has a Market Capitalization of 271896352 and an Enterprise Value of 238354272. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.72. Its current Enterprise Value per Revenue stands at 4.141 whereas that against EBITDA is -7.937.
Stock Price History:
The Beta on a monthly basis for AQST is 2.62, which has changed by -0.38956714 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, AQST has reached a high of $6.23, while it has fallen to a 52-week low of $2.24. The 50-Day Moving Average of the stock is -8.29%, while the 200-Day Moving Average is calculated to be -27.12%.
Shares Statistics:
AQST traded an average of 1.66M shares per day over the past three months and 1334620 shares per day over the past ten days. A total of 91.41M shares are outstanding, with a floating share count of 87.78M. Insiders hold about 11.22% of the company’s shares, while institutions hold 38.69% stake in the company. Shares short for AQST as of 1740700800 were 9978681 with a Short Ratio of 6.02, compared to 1738281600 on 11086624. Therefore, it implies a Short% of Shares Outstanding of 9978681 and a Short% of Float of 13.069999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
